Aric Logsdon, PhD, BS, PharmD

Biomedical Scientist with 15+ years experience conducting neuroscience research with specific expertise in blood-brain barrier physiology & traumatic brain injury. Trained in Basic Laboratory Technique, & versed in Scientific Communication and Leadership.

Organization:

West Virginia University School of Pharmacy

Department:

Pharmaceutical Sciences

Classification:

Faculty

Research Assistant Professor

Organization:

West Virginia University School of Pharmacy

Department:

Alumni Relations

Classification:

Faculty

• BS, Allegheny College
• PharmD, West Virginia University
• PhD, West Virginia University

1. Logsdon AF, Foresi BD, Hu S, Aarun H, Ingrid R, Asmit K et al., 2024 Perineuronal net deglycosylation associates with tauopathy-induced gliosis and neurodegeneration. J Neurochem. [ePub ahead of print].
2. Logsdon AF, Erickson MA, Herbert MJ, Noonan C, Foresi BD, Qiu J et al., 2023 Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption in neonatal mice. Exp. Neurol. [ePub ahead of print].
3. Logsdon AF, Francis KL, Richardson NE, Hu Shannon, Faber CL, Phan BA, Nguyen V et al., 2021 Decoding perineuronal net matrix sulfation patterns in the Alzheimer’s disease brain. Alzheimers Dement. [In Press].
4. Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA, 2021 Healthy Aging and the Blood-Brain Barrier. Nature Aging 1(3):243-254.
5. Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, Holden SJ, et al., 2021 The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nature Neurosci. 24(3):368-378.
6. Alonge KM, Mirzadeh Z, Scarlett JM, Logsdon AF, Brown JM, Cabrales E, Chan C et al., 2020 Hypothalamic perineuronal net assembly is required for sustained diabetes remission induced by fibroblast growth factor 1 in rats. Nature Metab. [Epub ahead of print].
7. Logsdon AF, Schindler A, Meabon JS, Yagi M, Herbert MJ, Banks WA, Raskind MA et al., 2020 Nitric oxide synthase mediates cerebellar dysfunction in mice exposed to repetitive blast-induced mild traumatic brain injury. Sci Rep. 10(1):9420.
8. Logsdon AF, Erickson MA, Chen X, Qui J, Lim Y, Stonestreet BS, Banks WA. 2020 Inter-alpha protein inhibitors attenuate inflammatory cytokines and blood-brain barrier disruption induced by lipopolysaccharide. JCBFM. 40(5):1090-1102.
9. Alonge KM, Logsdon AF, Murphree TA, Banks WA, Keene CD, Edgar JS, Whittington D, et al., 2019 Quantitative analysis of chondroitin sulfate disaccharides from human and rodent fixed brain tissue by electrospray ionization-tandem mass spectrometry. Glycobiology. 29(12):847-860.
10. Logsdon AF, Lucke-wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber JD. 2016 Salubrinal reduces neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Res 1643:140-51.

 

Symposia Chair, Brain & Brain PET, 2022

Session Chair, Brain & Brain PET, 2019

Poster Award, Cerebrovascular Biology, 2018

Trainee of the Year, University of Washington 2018

Poster Award, National Neurotrauma Society, 2017

Outstanding Graduate Student, West Virginia University, 2016

Graduate Student Research Award, West Virginia University, 2015

Accolades include Federal Grant Funding, High-impact Scientific Publications, and International Speaking Opportunities.

 

Dr. Aric Logsdon is an experienced biomedical researcher with a strong neuroscience background and expertise in preclinical drug discovery for human neurological diseases. Aric earned his PhD in Pharmaceutical Sciences from West Virginia University in 2016 and completed Postdoctoral training at the University of Washington under the mentorship of Drs. William A. Banks and David G. Cook.

Dr. Logsdon recently held a faculty appointment with the University of Washington Department of Medicine and served as a Health Science Specialist for the US Department of Veterans Affairs.

Dr. Logsdon has published over 50 peer-reviewed publications in high-impact scientific journals, including Nature Neuroscience, Nature Metabolism, Nature Aging and Alzheimer’s & Dementia. Aric is an acknowledged expert in neuroscience research and has been invited to chair sessions and present lectures of his work at multiple national and international scientific conferences. Dr. Logsdon is also the recipient of several honors and awards from research societies, including the Psychoneuroimmunology Research Society, the International Society for Cerebral Blood Flow and Metabolism, and the National Neurotrauma Society.

Dr. Logsdon is interested in elucidating the functional role(s) of brain glycans in preclinical models of traumatic brain injury and stroke. Dr. Logsdon employs innovative biochemical techniques to measure glycan composition, blood-brain barrier function and the neurological disease pathogenesis. Dr. Logsdon seeks to determine the causal relationship(s) between cerebrovascular dysfunction, brain glycan changes, and the development of Alzheimer’s disease clinicopathology. Results from this research may lead to novel drug discovery efforts for treating human neurological diseases.